SMS Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 249.62 | 175.48 | 198.05 |
| Operating Expense | 206.85 | 140.05 | 164.89 |
| Net Profit | 20.62 | 17.17 | 14.26 |
| Net Profit Margin | 8.26 | 9.78 | 7.20 |
| Earning Per Share | 2.43 | 2.03 | 1.68 |
| EBIDTA | 38.98 | 35.06 | 32.19 |
| Effective Tax Rate | 10.87 | 14.08 | 14.17 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 249.62 |
| Operating Expense | 206.85 |
| Net Profit | 20.62 |
| Net Profit Margin | 8.26 |
| Earning Per Share | 2.43 |
| EBIDTA | 38.98 |
| Effective Tax Rate | 10.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 709.26 | 522.05 | 519.87 |
| Operating Expenses Annual | 592.42 | 467.38 | 405.39 |
| Operating Profit Annual | 121.30 | 59.59 | 119.68 |
| Interest Annual | 23.46 | 21.91 | 18.88 |
| Depreciation | 30.01 | 30.79 | 30.49 |
| Net Profit Annual | 49.42 | 4.08 | 68.04 |
| Tax Annual | 16.91 | 1.47 | 0.62 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 709.26 |
| Operating Expenses Annual | 592.42 |
| Operating Profit Annual | 121.30 |
| Interest Annual | 23.46 |
| Depreciation | 30.01 |
| Net Profit Annual | 49.42 |
| Tax Annual | 16.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 7.31 | 46.58 | 40.42 |
| Cash Flow from Operations | 50.12 | 22.45 | 45.06 |
| Cash Flow from Investing | -52.07 | -29.76 | -27.15 |
| Cash Flow from Financing | 30.68 | -31.97 | -11.75 |
| Cash Flow at the End | 36.04 | 7.31 | 46.58 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 7.31 |
| Cash Flow from Operations | 50.12 |
| Cash Flow from Investing | -52.07 |
| Cash Flow from Financing | 30.68 |
| Cash Flow at the End | 36.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 16.14 | 10.76 | 21.60 |
| PBIT Margin (%) | 11.95 | 4.96 | 15.81 |
| PBT Margin (%) | 11.44 | 4.73 | 14.99 |
| Net PROFIT Margin (%) | 6.57 | 0.74 | 12.25 |
| Return On Networth / Equity (%) | 9.28 | 0.83 | 14.76 |
| Return On Networth /Employed (%) | 11.22 | 3.65 | 12.17 |
| Return On Assets (%) | 6.17 | 0.54 | 9.43 |
| Total Debt / Equity (X) | 0.50 | 0.52 | 0.56 |
| Asset Turnover Ratio (%) | 0.94 | 0.73 | 0.77 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 16.14 |
| PBIT Margin (%) | 11.95 |
| PBT Margin (%) | 11.44 |
| Net PROFIT Margin (%) | 6.57 |
| Return On Networth / Equity (%) | 9.28 |
| Return On Networth /Employed (%) | 11.22 |
| Return On Assets (%) | 6.17 |
| Total Debt / Equity (X) | 0.50 |
| Asset Turnover Ratio (%) | 0.94 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 437.26 | 412.02 | 437.99 |
| Total Current Assets Annual | 533.89 | 410.65 | 377.05 |
| Non Current Assets Annual | 534.36 | 503.54 | 505.92 |
| Total Shareholders Funds Annual | 570.49 | 495.10 | 493.76 |
| Total Assets Annual | 1,068.25 | 914.18 | 882.97 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 437.26 |
| Total Current Assets Annual | 533.89 |
| Non Current Assets Annual | 534.36 |
| Total Shareholders Funds Annual | 570.49 |
| Total Assets Annual | 1,068.25 |
EPS (INR)
Expected
2.29
Reported
2.40
Surprise
4.80%
Dec 2024
EPS beaten by 4.80%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.60%
